Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Carmofur | 61422-45-5 | 99.95% | 100 MG
Supplier: Medchemexpress LLC HYB0182100MG
Carmofur (HCFU) is a rat recombinant acid ceramidase inhibitor with an IC50 of 29 nM. It also acts as a protease inhibitor for SARS-CoV-2 main protease (Mpro), fatty acid amide hydrolase (FAAH), and N-acylethanolamine acid amidase (NAAA). This compound exhibits anti-cancer, anti-inflammatory, and anti-virus activities, making it suitable for studying COVID-19 and acute lung injury (ALI).
- Inhibits acid ceramidase (IC50: 29 nM)
- Acts as a protease inhibitor for SARS-CoV-2 Mpro
- Inhibits fatty acid amide hydrolase (FAAH)
- Inhibits N-acylethanolamine acid amidase (NAAA)
- Exhibits anti-cancer activity
- Exhibits anti-inflammatory activity
- Exhibits anti-virus activity
- Used for studying COVID-19 and acute lung injury (ALI)
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?